9-methyl-beta-carboline has been researched along with deoxyuridine in 1 studies
| Studies (9-methyl-beta-carboline) | Trials (9-methyl-beta-carboline) | Recent Studies (post-2010) (9-methyl-beta-carboline) | Studies (deoxyuridine) | Trials (deoxyuridine) | Recent Studies (post-2010) (deoxyuridine) |
|---|---|---|---|---|---|
| 10 | 0 | 5 | 2,256 | 22 | 446 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Enzensperger, C; Gille, G; Polanski, W; Reichmann, H | 1 |
1 other study(ies) available for 9-methyl-beta-carboline and deoxyuridine
| Article | Year |
|---|---|
The exceptional properties of 9-methyl-beta-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects.
Topics: Animals; Anti-Inflammatory Agents; Carbolines; Cells, Cultured; Cytokines; Deoxyuridine; Dopa Decarboxylase; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Gene Expression Regulation; L-Lactate Dehydrogenase; Lipopolysaccharides; Mesencephalon; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Piperazines; Pregnancy; Receptors, Cytokine; Regeneration; RNA, Messenger; Statistics, Nonparametric; Tyrosine 3-Monooxygenase | 2010 |